BriaCell Therapeutics Corp. Files 8-K
Ticker: BCTXZ · Form: 8-K · Filed: Aug 26, 2025 · CIK: 1610820
Sentiment: neutral
Topics: corporate-event, filing, pharmaceutical
Related Tickers: BCTX
TL;DR
BriaCell Therapeutics filed an 8-K on Aug 21, 2025, reporting 'Other Events' and financial exhibits.
AI Summary
BriaCell Therapeutics Corp. filed an 8-K on August 26, 2025, reporting an event that occurred on August 21, 2025. The filing indicates a change in the company's structure or operations, as it is categorized under 'Other Events' and includes financial statements and exhibits. The company, previously known as Ansell Capital Corp., is incorporated in British Columbia.
Why It Matters
This filing signals a significant corporate event or update for BriaCell Therapeutics Corp., potentially impacting its business operations, financial standing, or strategic direction.
Risk Assessment
Risk Level: medium — 8-K filings under 'Other Events' can cover a wide range of material changes, requiring further investigation to assess specific risks.
Key Players & Entities
- BriaCell Therapeutics Corp. (company) — Registrant
- Ansell Capital Corp. (company) — Former company name
- August 21, 2025 (date) — Earliest event date
- August 26, 2025 (date) — Filing date
FAQ
What specific 'Other Events' are detailed in this 8-K filing?
The provided text does not specify the 'Other Events'; it only indicates that this item is included in the filing.
What is the significance of the 'Financial Statements and Exhibits' being filed?
The filing of financial statements and exhibits suggests that material financial information or supporting documents related to the reported events are being disclosed.
When was BriaCell Therapeutics Corp. formerly known as Ansell Capital Corp. and when did the name change occur?
The filing states the former company name was Ansell Capital Corp. and the date of the name change was June 13, 2014.
What is the primary business of BriaCell Therapeutics Corp. according to the SIC code?
The Standard Industrial Classification (SIC) code provided is 2834, which corresponds to 'Pharmaceutical Preparations'.
Where is BriaCell Therapeutics Corp. incorporated and what is its business address?
BriaCell Therapeutics Corp. is incorporated in British Columbia (A1) and its business address is Suite 300 - 235 15th Street West Vancouver, BC V7T 2X1.
Filing Stats: 511 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2025-08-25 20:18:16
Filing Documents
- form8-k.htm (8-K) — 42KB
- ex99-1.htm (EX-99.1) — 13KB
- 0001641172-25-025438.txt ( ) — 270KB
- bctx-20250821.xsd (EX-101.SCH) — 4KB
- bctx-20250821_def.xml (EX-101.DEF) — 26KB
- bctx-20250821_lab.xml (EX-101.LAB) — 37KB
- bctx-20250821_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BRIACELL THERAPEUTICS CORP. /s/ William V. Williams August 25, 2025 William V. Williams President and Chief Executive Officer